125
Views
39
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls

, , , &
Pages 682-689 | Received 04 May 2005, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sanne Pagh Møller, Hiwot Amare, Dirk Lund Christensen, Daniel Yilma, Alemseged Abdissa, Henrik Friis, Daniel Faurholt-Jepsen & Mette Frahm Olsen. (2020) HIV and metabolic syndrome in an Ethiopian population. Annals of Human Biology 47:5, pages 457-464.
Read now
Anthony S. Wierzbicki, Scott D. Purdon, Timothy C. Hardman, Ranjababu Kulasegaram & Barry S. Peters. (2008) HIV lipodystrophy and its metabolic consequences: implications for clinical practice. Current Medical Research and Opinion 24:3, pages 609-624.
Read now

Articles from other publishers (37)

Grace Kisitu, Veronika Shabanova, Fairuzi Naiga, Mary Nakagwa, Adeodata R. Kekitiinwa, Peter J. Elyanu & Elijah Paintsil. (2023) High prevalence of low high‐density lipoprotein cholesterol and insulin resistance among children and adolescents living with HIV in Uganda: harbinger for metabolic syndrome? . HIV Medicine 25:2, pages 262-275.
Crossref
Dante S. Harbuwono, Nenfiati, Dicky L. Tahapary, Siti Setiati, Evy Yunihastuti & Tri Juli Edi Tarigan. (2023) Defining the optimum HOMA-IR cut-off value for insulin resistance among ARV-treated HIV patients in Indonesia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 17:2, pages 102719.
Crossref
Barry E. Hurwitz, Roger C. McIntosh & Jeffrey M. Greeson. 2022. Handbook of Cardiovascular Behavioral Medicine. Handbook of Cardiovascular Behavioral Medicine 1415 1441 .
Ruizi ShiXiaoxiao ChenHaijiang LinWeiwei ShenXiaohui XuBowen ZhuXiaoyi XuYingying DingFrank Y. WongNa He. (2020) Association of HIV infection with metabolic syndrome among normal or underweight young adults: evidence from the CHART cohort. BioScience Trends 14:6, pages 450-456.
Crossref
Daniel Vargas-Pacherrez, Helma P. Cotrim, Leonardo Pires, Vitor Cunha, Vitor Coelho, Carlos Brites & Carla Daltro. (2020) Metabolic Syndrome in HIV-patients in Antiretroviral Therapy. Current HIV Research 18:6, pages 388-395.
Crossref
Esther Rodríguez-Gallego, Josep Gómez, Yolanda M. Pacheco, Joaquim Peraire, Consuelo Viladés, Raúl Beltrán-Debón, Roger Mallol, Miguel López-Dupla, Sergi Veloso, Verónica Alba, Julià Blanco, Nicolau Cañellas, Anna Rull, Manuel Leal, Xavier Correig, Pere Domingo & Francesc Vidal. (2018) A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients. AIDS 32:5, pages 565-573.
Crossref
Suyanee Pongthananikorn, Kittiya Jantarathaneewat, Pondsarun Somnikha, Sirirat Jaturapullarp & Kulwara Meksawan. (2018) Prevalence and Risk Factors of Metabolic Syndrome in HIV-Infected Patients Receiving the Highly Active Antiretroviral Therapy. Topics in Clinical Nutrition 33:1, pages 41-49.
Crossref
Fakhraddeen Yahya Muhammad, Ibrahim Danjummai Gezawa, Andrew Uloko, Ahmad Maifada Yakasai, Abdulrazaq Garba Habib & Garba Iliyasu. (2017) Metabolic syndrome among HIV infected patients: A comparative cross sectional study in northwestern Nigeria. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 11, pages S523-S529.
Crossref
Chidozie U. Nduka, Saverio Stranges, Peter K. Kimani, Ahmed M. Sarki & Olalekan A. Uthman. (2017) Is there sufficient evidence for a causal association between antiretroviral therapy and diabetes in HIV‐infected patients? A meta‐analysis. Diabetes/Metabolism Research and Reviews 33:6.
Crossref
Sivaraj NaiduSasheela PonnampalvanarShahrul Bahyah KamaruzzamanAdeeba Kamarulzaman. (2017) Prevalence of Metabolic Syndrome Among People Living with HIV in Developing Countries: A Systematic Review. AIDS Patient Care and STDs 31:1, pages 1-13.
Crossref
C U Nduka, S Stranges, A M Sarki, P K Kimani & O A Uthman. (2015) Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis. Journal of Human Hypertension 30:6, pages 355-362.
Crossref
Raquel Martin-Iguacel, Eugènia Negredo, Robert Peck & Nina Friis-Møller. (2016) Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV. Current Hypertension Reports 18:6.
Crossref
Kim A. Nguyen, Nasheeta Peer, Edward J. Mills & Andre P. Kengne. (2016) A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population. PLOS ONE 11:3, pages e0150970.
Crossref
Alex K. BryantPariya L. FazeliScott L. LetendreRonald J. EllisMichael PotterTricia H. BurdoKumud K. SinghDilip V. JesteIgor GrantDavid J. Moore. (2016) Complement Component 3 Is Associated with Metabolic Comorbidities in Older HIV-Positive Adults. AIDS Research and Human Retroviruses 32:3, pages 271-278.
Crossref
Chidozie Nduka, Ahmed Sarki, Olalekan Uthman & Saverio Stranges. (2015) Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: A systematic review and meta-analysis. International Journal of Cardiology 199, pages 307-318.
Crossref
Cecilia Colombero, Gabriel Catano, Carlos A. Rocco, Débora Mecikovsky, Rosa Bologna, Paula C. Aulicino, Luisa Sen & Andrea Mangano. (2015) Role of 3 Lipoprotein Lipase Variants in Triglycerides in Children Receiving Highly Active Antiretroviral Therapy. Pediatric Infectious Disease Journal 34:2, pages 155-161.
Crossref
Jureeporn JantarapakdeNittaya PhanuphakChintana ChaturawitSupabhorn PengnonyangPornpen MathajittiphanPiyaporn TakamthaNarunat DungjunSuteeraporn PinyakornWarabhorn PimaWisit PrasithsirikulPraphan Phanuphak. (2014) Prevalence of Metabolic Syndrome Among Antiretroviral-Naive and Antiretroviral-Experienced HIV-1 Infected Thai Adults. AIDS Patient Care and STDs 28:7, pages 331-340.
Crossref
Demo Yemane Tesfaye, Samuel Kinde, Girmay Medhin, Yoseph Cherinet Megerssa, Agete Tadewos, Endale Tadesse & Techalew Shimelis. (2014) Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 8:2, pages 102-107.
Crossref
Alessandro MalobertiChristina GiannattasioDario DozioMauro BetelliPaulo VillaStefano NavaFrancesca CesanaRita FacchettiLuca GiupponiFrancesco CastagnaFrancesca SabbatiniAlessandra BanderaAndre GoriGuido GrassiGiuseppe Mancia. (2013) Metabolic Syndrome in Human Immunodeficiency Virus–Positive Subjects: Prevalence, Phenotype, and Related Alterations in Arterial Structure and Function. Metabolic Syndrome and Related Disorders 11:6, pages 403-411.
Crossref
Supriya Krishnan, Jeffrey T. Schouten, Benjamin Atkinson, Todd Brown, David Wohl, Grace A. McComsey, Marshall J. Glesby, Cecilia Shikuma, Richard Haubrich, Pablo Tebas, Thomas B. Campbell & Denise L. Jacobson. (2012) Metabolic Syndrome Before and After Initiation of Antiretroviral Therapy in Treatment-Naive HIV-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes 61:3, pages 381-389.
Crossref
Olugbenga Edward AyodeleAdeolu Oludayo AkinboroSuliat Omolola AkinyemiAkinlawon Adetiloye AdepejuOluwaseun Akinsanmi AkinremiChristiana Adeola AlaoAdetoun Adedayo Popoola. (2012) Prevalence and Clinical Correlates of Metabolic Syndrome in Nigerians Living with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Metabolic Syndrome and Related Disorders 10:5, pages 373-379.
Crossref
Paolo Bonfanti, Giuseppe Vittorio De Socio, Elena Ricci, Andrea Antinori, Canio Martinelli, Francesca Vichi, Giovanni Penco, Giordano Madeddu, Giancarlo Orofino, Laura Valsecchi, Stefano Rusconi, Barbara Menzaghi, Daria Pocaterra & Tiziana Quirino. (2012) The feature of Metabolic Syndrome in HIV naive patients is not the same of those treated: Results from a prospective study. Biomedicine & Pharmacotherapy 66:5, pages 348-353.
Crossref
Angela MarzocchettiJessica SchwarzSimona Di GiambenedettoManuela ColafigliLaura BraccialeMassimilliano FabbianiMassimo FantoniEnrico TrecarichiRoberto CaudaAndrea De Luca. (2011) The Effect of Polymorphisms in Candidate Genes on the Long-Term Risk of Lipodystrophy and Dyslipidemia in HIV-Infected White Patients Starting Antiretroviral Therapy. AIDS Research and Human Retroviruses 27:12, pages 1299-1309.
Crossref
Signe W. Worm & Jens D. Lundgren. (2011) The metabolic syndrome in HIV. Best Practice & Research Clinical Endocrinology & Metabolism 25:3, pages 479-486.
Crossref
Signe W Worm, Nina Friis-Møller, Mathias Bruyand, Antonella D'Arminio Monforte, Martin Rickenbach, Peter Reiss, Wafaa El-Sadr, Andrew Phillips, Jens Lundgren & Caroline Sabin. (2010) High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. AIDS 24:3, pages 427-435.
Crossref
Nicola Squillace, Stefano Zona, Chiara Stentarelli, Gabriella Orlando, Barbara Beghetto, Giulia Nardini, Roberto Esposito & Giovanni Guaraldi. (2009) Detectable HIV Viral Load Is Associated With Metabolic Syndrome. JAIDS Journal of Acquired Immune Deficiency Syndromes 52:4, pages 459-464.
Crossref
JE Forrester, BH McGovern, MS Rhee & RK Sterling. (2009) The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high‐risk Hispanic population. HIV Medicine 10:9, pages 555-563.
Crossref
HM Crane, C Grunfeld, RD Harrington & MM Kitahata. (2009) Lipoatrophy and lipohypertrophy are independently associated with hypertension * . HIV Medicine 10:8, pages 496-503.
Crossref
BR Hansen, J Petersen, SB Haugaard, S Madsbad, N Obel, Y Suzuki & O Andersen. (2009) The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy. HIV Medicine 10:6, pages 378-387.
Crossref
Sang Hoon Han, Bum Sik Chin, Hee Kyoung Choi, So Youn Shin, Yun Tae Chae, Ji-Hyeon Baek, Chang Oh Kim, Jun Yong Choi, Young Goo Song, Hyun Chul Lee & June Myung Kim. (2009) Prevalence of and Clinical Factors Associated with Lipoatrophy in HIV-Infected Koreans Receiving Highly Active Antiretroviral Therapy. The Tohoku Journal of Experimental Medicine 219:2, pages 145-153.
Crossref
Magdalena E Sobieszczyk, Donald R Hoover, Kathryn Anastos, Kathleen Mulligan, Tianren Tan, Qiuhu Shi, Wei Gao, Charles Hyman, Mardge H Cohen, Stephen R Cole, Michael W Plankey, Alexandra M Levine & Jessica Justman. (2008) Prevalence and Predictors of Metabolic Syndrome Among HIV-Infected and HIV-Uninfected Women in the Women's Interagency HIV Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 48:3, pages 272-280.
Crossref
Maribel Rodríguez-Torres, Sugantha Govindarajan, Ricard Solá, Nathan Clumeck, Eduardo Lissen, Mário Pessôa, Peter Buggisch, Janice Main, Jean DePamphilis & Douglas T. Dieterich. (2008) Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study. Journal of Hepatology 48:5, pages 756-764.
Crossref
Eugene Mutimura, Nigel J. Crowther, Aimee Stewart & W. Todd Cade. (2008) The Human Immunodeficiency Virus and the Cardiometabolic Syndrome in the Developing World: An African Perspective. Journal of the CardioMetabolic Syndrome 3:2, pages 106-110.
Crossref
N Squillace, G Lapadula, C Torti, G Orlando, S Mandalia, G Nardini, B Beghetto, S Costarelli & G Guaraldi. (2008) Hepatitis C virus antibody‐positive patients with HIV infection have a high risk of insulin resistance: a cross‐sectional study. HIV Medicine 9:3, pages 151-159.
Crossref
Giuseppe Vittorio L. De Socio, Paolo Bonfanti, Elena Ricci, Giancarlo Orofino, Giordano Madeddu, Giovanni Penco, Erika Gianelli, Canio Martinelli, Silvia Carradori, Tiziana Quirino & Giuliano Rizzardini. (2008) Cholesterol levels in HIV–HCV infected patients treated with lopinavir/r: Results from the SCOLTA project. Biomedicine & Pharmacotherapy 62:1, pages 16-20.
Crossref
Vivian Pao, Grace A. Lee & Carl Grunfeld. (2008) HIV therapy, metabolic syndrome, and cardiovascular risk. Current Atherosclerosis Reports 10:1, pages 61-70.
Crossref
Johan N. Bruun, Linda Skeie, Arild Mæland, Susanne G. Dudman, Mette Sannes og & Vidar Ormaasen. (2007) Fra dødelig syndrom til kronisk sykdom. Den norske tannlegeforenings Tidende 117:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.